Suggestions
Nicolas Lindegger
Medical Director - EU - Breast Cancer at Seattle Genetics
Nicolas Lindegger is a seasoned medical professional with a diverse background in cardiac physiology, ion channel electrophysiology, pharmacology, and spectroscopy. After completing his Ph.D. at the University of Bern, he delved into researching cardiac arrhythmias at Columbia University. Transitioning to the pharmaceutical industry, Nicolas held roles at Actelion and Novartis, where he spearheaded phase I and proof-of-concept clinical studies. His tenure at Roche's Global Medical Affairs saw him as an International Scientific Director focusing on HER2 positive breast cancer, shaping the clinical development plan for various treatments.